NCT06232421View on ClinicalTrials.gov

Clinical Study in Adult Patients With Purulent-inflammatory Processes of the Skin and Soft Tissues, Phase I-II of the Wound Process

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

May 31, 2026

Conditions
Diabetic Foot InfectionsChronic Venous Insufficiency
Interventions
DRUG

Foscelantan

"Foscelantan, medicinal plate 4.0x5.0 cm in package No. 1 produced by UNITEHPROM BSU, Republic of Belarus"

DRUG

Povidon-iodine

Povidone-iodine solution 100 mg/ml produced by BelAseptika CJSC, Republic of Belarus

Trial Locations (2)

210037

Health care institution Vitebsk Regional Clinical Hospital, Vitebsk

220096

10th CITY CLINICAL HOSPITAL, Minsk

All Listed Sponsors
collaborator

Vitebsk Regional Clinical Hospital

OTHER_GOV

collaborator

Unitary Enterprise UNITEHPROM BSU

UNKNOWN

collaborator

The 10th Minsk City Clinical Hospital

UNKNOWN

lead

Research Institute for Physical Chemical Problems of the Belarusian State University

OTHER